Does the FDA approve HRT for early menopause

DISCLOSURE: Voshell's Pharmacy is a licensed compounding pharmacy that prepares and sells compounded medications by prescription. As a provider of competing products, our perspective may be influenced by our professional and commercial interests.

According to FDA.gov, the FDA has approved hormone therapy products for early menopause. Replacing estrogen when the ovaries stop working too early is among the recognized medical uses of FDA-approved hormone therapy.

What this approval actually means

According to FDA-approved prescribing information for estrogen-containing products, the FDA has approved various estrogen medications — and estrogen plus progesterone for women with a uterus — specifically for vasomotor symptoms such as hot flashes, for vaginal and urinary changes, and for prevention of bone loss. These symptoms and health risks occur in both natural menopause and early menopause, so the same FDA approvals apply.

Early menopause means the ovaries stop producing hormones before age 45. If this happens before age 40, it is called primary ovarian insufficiency (POI). In both situations, estrogen levels fall too early and remain too low for too long. Because of that, FDA-approved estrogen therapy is considered an appropriate and important treatment option by qualified prescribers.

Compounded medications are not reviewed by FDA for safety or effectiveness before dispensing and are prepared by a licensed pharmacist only in response to a valid prescription for an individual patient. This page primarily discusses commercially available hormone therapy products.

Why therapy is recommended in early menopause

• Bone protection: According to FDA-approved prescribing information, women who lose estrogen early face higher risk for osteoporosis. FDA-approved estrogen products are indicated for prevention of postmenopausal osteoporosis.
• Symptom relief: According to FDA.gov, hot flashes, night sweats, and related vasomotor symptoms are recognized indications for FDA-approved estrogen therapy.
• Broader health considerations: According to NAMS, estrogen supports multiple physiologic systems. Restoring hormone levels through commercially available products addresses deficiencies that arise when the ovaries stop functioning earlier than expected.

A simple way to think about it

According to ACOG, women with early menopause or POI are typically advised to use hormone therapy until the average age of natural menopause, unless a specific contraindication exists. The goal is to address the hormone deficiency that occurs earlier than it would naturally.

According to FDA-approved prescribing information, if a woman still has her uterus, she also needs an approved form of progesterone to protect the uterine lining. If her uterus has been removed, estrogen alone may be appropriate, as determined by a qualified prescriber.

The bottom line: According to FDA.gov, the FDA has approved hormone therapy products for the symptoms and health consequences of early menopause. A qualified prescriber can evaluate whether such treatment is appropriate for an individual patient.